A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...

Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss copycats.

News last week that a CNN investigative report found dozens of fake podcasts on the popular audio streaming and media service platform Spotify, illegally ...

The telehealth site will welcome its own small-dose, compounded version of semaglutide, which mimics the function of a GLP-1.

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...

A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

"If a Greek family starts a pizzeria, if a Chinese family straight from Beijing opens a hot dog shop, are they appropriating or are they just smart?" says the Food for Thought author and former Good ...

Novo Nordisk CEO Lars Jørgensen to step down amid increasing pressure from obesity drug competition and recent share price ...

A Trump administration plan to slash prescription drug prices by tying them to international markets will likely have minimal ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...